Cannabis Regulatory Update: FDA On CBD Reg Stalling, NY Issues 58 Cannabis Grow Licenses, LA’s State Worker ProtectionsPosted by On

FDA Chief Recognizes Slow Progress On CBD Regulations  

Dr. Robert M. Califf confirmed on Thursday at a congressional panel that the FDA has made little progress on the regulatory framework around CBD products over the years since Trump signed the Farm Bill in late 2018.

 “It looks pretty much the same in terms of where we are now,” Califf told a House Appropriations subcommittee hearing that also tackled the baby formula shortage and therapeutic use of kratom, reported Marijuana Moment.

 “We just know more because we’ve done more research,” Califf said, further noting “the amazing plethora derivatives of the cannabis plant [are] surely quite profound and astounding and already in widespread use for a variety of means.”

Califf explained that the FDA needs Congressional help to get this done.

Rep. Dan Newhouse (R-WA) pointed out that the lack of FDA regulations on CBD and other hemp-derived products has made a mess across the U.S. “I believe we’re still waiting on FDA for some action to be taken,” Newhouse said. “Currently the industry is in a state of uncertainty because of no direction.”

Rep. Mark Pocan (D-WI) urged the agency to take action. “Technically CBD’s sale, in the eyes of the FDA, is illegal,” he said. “What is FDA’s plan to clarify that CBD could possibly be regulated as a food or food additive, and is there any timeline?”

To this, Califf responded that studies have uncovered some risks with CBD and that the agency…

Original Author Link click here to read complete story..

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.